<https://serval.unil.ch/notice/serval:BIB_86BBC6AFEB18#id>	<http://id.loc.gov/vocabulary/relators/aut>	<http://www.idref.fr/077646215/id> .
<https://serval.unil.ch/notice/serval:BIB_86BBC6AFEB18#id>	<http://id.loc.gov/vocabulary/relators/aut>	<http://www.idref.fr/242247423/id> .
<https://serval.unil.ch/notice/serval:BIB_86BBC6AFEB18#id>	<http://purl.org/dc/elements/1.1/date>	"2020-09" .
<https://serval.unil.ch/notice/serval:BIB_86BBC6AFEB18#id>	<http://id.loc.gov/vocabulary/relators/aut>	<http://www.idref.fr/242247571/id> .
<https://serval.unil.ch/notice/serval:BIB_86BBC6AFEB18#id>	<http://purl.org/ontology/bibo/doi>	"10.1007/s00259-020-04757-3" .
<https://serval.unil.ch/notice/serval:BIB_86BBC6AFEB18#id>	<http://id.loc.gov/vocabulary/relators/aut>	<http://www.idref.fr/157876403/id> .
<https://serval.unil.ch/notice/serval:BIB_86BBC6AFEB18#id>	<http://purl.org/dc/terms/bibliographicCitation>	"Seban R.D., Moya-Plana A., Antonios L., Yeh R., Marabelle A., Deutsch E., Schwartz L.H., G\u00F3mez RGH, Saenger Y., Robert C., Ammari S., Dercle L.. Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4.2020." .
<https://serval.unil.ch/notice/serval:BIB_86BBC6AFEB18#id>	<http://id.loc.gov/vocabulary/relators/aut>	<http://www.idref.fr/193732319/id> .
<https://serval.unil.ch/notice/serval:BIB_86BBC6AFEB18#id>	<http://id.loc.gov/vocabulary/relators/aut>	<http://www.idref.fr/118685589/id> .